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SUMMARY. Gastric ulcer is one of ulcerous diseases and may result in some changes of many enzymes
and transporters concerned with metabolism and disposal of drug. The pharmacokinetic of drug should
be different between peptic ulcer and normal animals. Lansoprazole has been one of important medicine
for treatment of ulcerous diseases. So, this paper investigated the difference of pharmacokinetic profiles of
lansoprazole in gastric ulcer and normal rabbits in vivo by HPLC-DAD method. In this work, a liquid-liq-
uid extraction and enrichment method with RP-HPLC determination route was taken. The pharmacoki-
netic parameters were analyzed by double-compartmental method (DAS2.0). The pharmacokinetic pa-
rameters of lansoprazole in normal and ulcer rabbits were as follows: (614.42 ± 152.25) and (875.73 ±
316.34) mg  h/L for AUC(0-6.5); (0.68 ± 0.12) and (0.83 ± 0.22) h for MRT(0-6.5), (0.52 ± 0.23) and (0.87 ±
0.42) h for t1/2; (6.13 ± 2.11) and (2.54 ± 1.65) L/h/kg for CL, respectively. Those results indicate that the
pharmacokinetic profiles of lansoprazole were changed by gastric ulcer. 
